| Health / Medical Topics |
BIBF 1120
A substance being studied in the treatment of some types of cancer. BIBF 1120 blocks enzymes needed for cells to grow, and may prevent the growth of new blood vessels that tumors need to grow. It is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called tyrosine kinase inhibitor BIBF 1120. (NCI Dictionary)
YOU MAY ALSO LIKE
In a scientific research study or clinical trial, a flaw in the study design or the method of collecting or interpreting…
A 1-beta-methylcarbapenem antibiotic with a wide range of antibacterial activity. Biapenem has similar antibacterial activity to that of imipenem, but is more…
A substance that is put on the skin to help repair damaged skin. It may be used on certain wounds and…
Autologous tumor cells transfected with a plasmid expressing recombinant human granulocyte macrophage-colony stimulating factor (rhGM-CSF) and bifunctional short hairpin RNA (bi-shRNA) against…
A method used by radiologists to interpret and report in a standardized manner the results of mammography, ultrasound, and MRI used in…
A bi-functional alkylating agent, with potential antineoplastic activity. Upon administration, VAL-083 crosses the blood brain barrier (BBB) and appears to be selective…
